Credit: Blue Planet Studio/Adobe Stock Deal Watch: Latham, Goodwin, Covington Steer Life Sciences Deals. And Is It Time for an M&A Rebound?
Near-record highs of private equity dry powder and corporate cash reserves are paired with high interest rates and other factors. Which will win out?
August 07, 2023 at 04:26 PM
10 minute read
Mergers and Acquisitions
With a recession less likely this year, is the timing—after all these months—ripe for a rebound in deal work?
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
- Cooley
- Paul Hastings
- White & Case
- Cleary Gottlieb Steen & Hamilton
- Kirkland & Ellis
- Reed Smith
- Cravath, Swaine & Moore
- Weil, Gotshal & Manges
- Skadden, Arps, Slate, Meagher & Flom LLP
- Davis Polk & Wardwell
- Loeb & Loeb
- Venable
- Simpson Thacher & Bartlett
- Amarchand & Mangaldas & Suresh A Shroff & Co
- Sullivan & Cromwell LLP
- Goodwin Procter
- Watson Farley & Williams
- Debevoise & Plimpton
- Morgan, Lewis & Bockius
- Katten Muchin Rosenman
- Nelson Mullins Riley & Scarborough
- Linklaters
- Parsons Behle Latimer
- Paul, Weiss, Rifkind, Warton & Garrison
- Sidley Austin
- Covington & Burling
- Ellenoff Grossman And Schole Llp
- Norton Rose Fulbright
- Latham & Watkins
- Wells Fargo
- Korea Electric Power
- Deutsche Bank
- Banco Santander
- Booz Allen Hamilton
- Ernst & Young
- Morgan Stanley
- British American Tobacco
- JPMorgan Chase
- UBS Group
- Citigroup
- Barclays
- TripAdvisor, Inc
- Goldman Sachs Group
- Chevron
- TPG Capital
- U.S. Securities and Exchange Commission
- Massachusetts
- Pfizer
- Fifth Third Bancorp
- Jefferies Financial Group
- RBC Capital Markets
- AstraZeneca
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
